REVELIO’s Unexposed Reference Group Was Designed to Track Changes Across Repeated Drives

The REVELIO protocol uses repeated drives in an unexposed reference group to help distinguish cannabis-related changes from learning, fatigue and habituation. A change after dosing in the exposed group alone would not answer that comparison.

The design includes a time structure

All participants are scheduled for a sober baseline and subsequent driving sessions. The reference group repeats driving without cannabis administration. The analysis plan includes session-specific models for the approximately one-to-two, three-to-four and five-to-six-hour windows, as well as within-person and between-group comparisons.

The reference group addresses a plausible alternative

Practice may improve some measures, while fatigue or repeated exposure to the track may change others. The reference group can provide information about those changes under the study conditions. It does not establish that every time-related influence is identical in exposed and unexposed participants.

The publication reports a plan

No completed time-course, false-positive rate or detection threshold follows from the protocol. Its reference design can support evaluation of whether sensor changes are cannabis-specific within the experiment. It cannot establish how a future model distinguishes cannabis from all other causes of altered driving. The useful contribution is a defined comparison for repeated-session effects, with the actual results and broader specificity still awaiting evaluation.

Related analysis: the source’s broader findings and limitations.

Research cited

Deuber and colleagues (2026). Protocol for the REVELIO test-track pilot study: A randomised, controlled, single-centre trial in healthy recreational cannabis users investigating real-time in-vehicle detection of cannabis-impaired driving.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

The scan-anxiety study ultimately randomized twenty-five participants to each treatment. The paper disclosed that its original sample-size plan anticipated a two-to-one allocation instead. The discrepancy concerned the allocation ratio The central registrar inadvertently implemented a one-to-one scheme rather than the originally intended unequal ratio. Participants still underwent randomized assignment, and…

Spread the love

Read Article: The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The scan-anxiety trial stratified randomization by baseline anxiety severity, but only six participants were in its severe category. Stratification did not supply enough data for a reliable severe-anxiety subgroup analysis. The strata helped organize allocation Participants were assigned within GAD-7 categories covering mild-to-moderate and severe anxiety. Of the fifty women…

Spread the love

Read Article: Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

The trial’s acute anxiety assessment occurred after CBD dosing but generally before the scheduled cancer scan. It did not directly measure whether CBD reduced distress inside the scanner. The two timing intervals were different Participants received the study drug within 48 hours before a tumor-assessment scan. Anxiety was reassessed two…

Spread the love

Read Article: The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us